2-[(4-Chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethylethanamine maleate salt
CAS: 3505-38-2
Rif. 3D-FC19699
2g | 180,00 € | ||
5g | 260,00 € | ||
10g | 357,00 € | ||
25g | 475,00 € | ||
50g | 775,00 € |
Informazioni sul prodotto
- AllergefonClistinCarbinoxamine maleate salt
- 2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine
- 2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine (2Z)-but-2-enedioate
- 2-[p-Chloro-α-[2-(dimethylamino)ethoxy]benzyl]pyridine Bimaleate
- 2-[p-Chloro-α-[2-(dimethylamino)ethoxy]benzyl]pyridine maleate
- Allergefon
- Allergefon maleate
- Carbinoxamine Hydrogen Maleate
- Carbinoxamine Maleate Salt
- Ciberon
- Vedi altri sinonimi
- Clistin
- Clistine Maleate
- Cliston
- Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-, (2Z)-2-butenedioate (1:1)
- Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-, (Z)-2-butenedioate (1:1)
- Hislosine
- Lergefin
- NSC 62362
- Paracarbinoxamine maleate
- Polistin T-Caps
- Pyridine, 2-[p-chloro-α-[2-(dimethylamino)ethoxy]benzyl]-, maleate (1:1)
- Rondec
- Rondec DM
2-[(4-Chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethylethanamine maleate salt (DCLM) is a controlled-release preparation of an antihistamine that is used for the relief of allergic symptoms. It is a prodrug that is hydrolyzed to 2-[(4-chlorophenyl)-2-pyridinylmethoxy]ethanol (DCPEM) in vivo. DCLM has been shown to be effective against viruses and has been found to have receptor activity in human serum. The drug can be administered either orally or by injection. DCLM has also been shown to suppress allergic symptoms in vitro with LC-MS/MS analysis.
Proprietà chimiche
Richiesta tecnica su: 3D-FC19699 2-[(4-Chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethylethanamine maleate salt
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.